Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

ISSN： 1741-0541

Source： Personalized Medicine, Vol.7, Iss.1, 2010-01, pp. : 33-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics- and pharmacogenomics-based rational clinical trial designs in oncology

By Qin Rui Kohli Manish

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 859-869

Future Medicine

Access to resources Recommend Favorite

The cetuximab experience: developing predictive biomarkers in oncology

By Harbison Christopher T Horak Christine E Khambata-Ford Shirin

Personalized Medicine, Vol. 8, Iss. 2, 2011-03 ,pp. : 149-159

Future Medicine

Access to resources Recommend Favorite

The mechanistic, diagnostic and prognostic utility of biomarkers in severe malaria

By Manning Laurens Davis Timothy Mark Earls

Biomarkers in Medicine, Vol. 7, Iss. 3, 2013-06 ,pp. : 363-380

Future Medicine

Access to resources Recommend Favorite

Evaluating prognostic accuracy of biomarkers in nested casecontrol studies

By Cai Tianxi Zheng Yingye

Biostatistics, Vol. 13, Iss. 1, 2012-01 ,pp. : 89-100

Oxford University Press

Access to resources Recommend Favorite

Clinical Biomarkers in Oncology: Focus on Colorectal Cancer

By > Biesmans Bart > Tejpar Sabine

Molecular Diagnosis & Therapy, Vol. 13, Iss. 2, 2009-04 ,pp. : 103-114

Adis International

Access to resources Recommend Favorite